To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Agriculture and Food119-hr679 — To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.. Sponsored by Rep. Harshbarger, Diana [R-TN-1]. Introduced 2025-01-23. House bill. 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce.
- Sponsor
- Rep. Harshbarger, Diana [R-TN-1] (R), TN
- Introduced
- 2025-01-23
- Committees
- Energy and Commerce Committee
- Subjects
- Abortion; Drug safety, medical device, and laboratory regulation; Drug therapy; Prescription drugs
- Latest Action
- Referred to the House Committee on Energy and Commerce.
No roll-call vote data available for this bill.
Similar Bills
- 118-hr4368 — To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes. 89% match 118th Congress
- 118-hr5850 — To nullify modifications made by the Food and Drug Administration on January 3, 2023, to the risk evaluation and mitigation strategy under section 505-1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1) for mifepristone, and for other purposes. 61% match 118th Congress
- 118-hr383 — Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 27% match 118th Congress
- 118-hr384 — Protecting Life from Chemical Abortions Act 23% match 118th Congress
- 117-hr9657 — Protecting Life from Chemical Abortions Act 22% match 117th Congress
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis